Current management of male-to-female gender identity disorder in the UK

Postgraduate Medical Journal

Volumn 83, Issue 984, 2007, Pages 638-642

  Tugnet, Nicola ^a   Goddard, Jonathan Charles ^a   Vickery, Richard M ^a   Khoosal, Deenesh ^a   Terry, Tim R ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; CYPROTERONE ACETATE; ESTROGEN; FINASTERIDE; GONADORELIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; SPIRONOLACTONE;

BEHAVIOR GENETICS; CLINICAL PRACTICE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ESTHETIC SURGERY; FEMINIZATION; GENDER IDENTITY DISORDER; GENETIC ASSOCIATION; HEREDITY; HORMONE BINDING; HORMONE METABOLISM; HUMAN; MENTAL HEALTH SERVICE; PATIENT ASSESSMENT; PERSONAL EXPERIENCE; POSTOPERATIVE PERIOD; REVIEW; SEX DIFFERENCE; SPEECH THERAPY; SURGICAL TECHNIQUE; TRANSSEXUALISM;

FEMALE; GENITALIA; HUMANS; MALE; TRANSSEXUALISM; UROGENITAL SURGICAL PROCEDURES;

EID: 35649015758     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.060533     Document Type: Review

References (39)

1. Stoller RJ. Sex and gender: on the development of masculinity and femininity, The Hogarth Press, 1968.
2. Hirschfeld M. Die intersexualle constitution [The intersexual state]. Jahrb sex zwischenstufen 1923;23:3-27.
3. Selvaggi G, Ceulmans P, De Cuypere G, et al. Gender identity disorder: general overview and surgical treatment for vaginoplasty in male-to-female transsexuals. Plast Reconstr Surg 2005;116:135e- 45e.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1995.
5. Wylie K. ABC of sexual health: gender related disorders. BMJ 2004;329:615-7.
6. Gooren L. The endocrinology of transsexualism: a review and commentary. Psychoneuroendocrinology 1990;15:3-14.
7. Wylie K. Good practice guidelines for the assessment and treatment of gender dysphoria. UK: Intercollegiate Working Party, 2006.
8. Michel A, Mormont C, Legros JJ. A psycho-endocrinological overview of transsexualism. Eur J Endocrinol 2001;145:365-76.
9. Hartmann U, Becker H. Storungen der geslechtsidentitat: ursachen, verlauf, therapie. Vienna: Springer Verlag, 2002;16.
10. Benjamin H. The transsexual phenomenon. New York: Julian Press, 1966.
11. Zhou J-N, Hofman MA, Gooren LJ, et al. A sex difference in the human brain and its relation to transsexuality. Nature 1995;378:68-70.
12. Kruijver FP, Zhou JN, Pool CW, et al. Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab 2000;85:2034-41.
13. Price VH. Treatment of hair loss. N Engl J Med 1999;341:964-73.
14. Dahl M, Feldman J, Goldberg J, et al. Endocrine therapy for transgender adults in British Columbia: suggested guidelines. Vancouver: Transcare Project, 2006.
15. Basson RJ. Towards optimal hormonal treatment of male to female gender identity disorder. J Sexual Repro Med 2001;1:45-51.
16. Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes and adverse effects. J Clin Endocrinol Metab 2003;88:3467-73.
17. Van Kesteren P, Asscheman H, Megens J, et al. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 1997;47:337-42.
18. Asscheman H, Gooren LJ, Assies J, et al. Prolactin levels and pituitary enlargement in hormone-treated male to female transsexual people. Clin Endocrinol (Oxf) 1988;28:583-8.
19. Gooren L, Assies J, Asscheman H, et al. Eestrogen-induced prolactinoma in a man. J Clin Endocrinol Metab 1988;66:444-6.
20. Kanhai R, Hage J, Asscheman H, et al. Augmentation mammaplasty in male to female transsexual people. Plast Reconstr Surg 1999;104:542-9.
21. Krege S, Bex G, Lummen G, et al. Male to female transsexualism: a technique, results and long term follow-up in 66 patients. Br J Urol 2001;88:396-402.
22. Rubin SO. A method of preserving the glans penis as a clitoris in sex conversion operations in male transsexuals. Scand J Urol Nephrol 1980;800:215-7.
23. Fang RH, Chen CF, Ma S. A new method for clitoroplasty in male-to-female sex reassignment surgery. Plast Reconstr Surg 1992;89:679-82.
24. Rehman J, Melman A. Formation of neoclitoris from glans penis by reduction glansplasty with preservation of neurovascular bundle in male to female gender surgery: functional and cosmetic outcome. J Urol 1999;161:200-6.
25. Hage JJ, Goedkoop AY, Karim RB, et al. Secondary corrections of the vulva in male-to-female transsexuals. Plast Reconstr Surg 2000;106:350-9.
26. Lawrence A. Factors associated with satisfaction or regret following male-to-female sex reassignment surgery. Arch Sex Behav 2003;32:299-315.
27. Anon. Gender Reassignment Surgery in Leicester. http://www.grsterry.com/results.htm (accessed 15 January 2007).
28. Eldh J, Berg A, Gustafsson M. Long term follow-up after sex reassignment surgery. Scand J Plast Reconstr Surg Hand Surg 1997;31:39-45.
29. Meyer WJ, Bochting W, Cohen-Kettenis P, et al. The standards of care for gender identity disorders, 6th ed. Mineapolis, Minnesota: Harry Benjamin International Gender Dysphoria Association, 2001.
30. Asscheman H, Gooren LJG. Hormone treatment in transsexuals. J Psychol Human Sexuality 1992;5:39-54.
31. Futterweit W. Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch Sex Behav 1998;27:209- 26.
32. Meyer WJ, Finkelstein JW, Stuart CA, et al. Physical and hormonal evaluation of transsexual patients during hormonal therapy. Arch Sex Behav 1981;10:347-56.
33. Schlatterer K, von Werder K, Stalla GK. Multistep treatment concept of transsexual patients. Experiment Clin Endocrinol Diabetes 1996;104:413-9.
34. Castro-Mission Health Centre. Dimensions. Informed consent for oestrogen therapy for male to female transition. San Francisco: Castro-Mission Health Centre, San Francisco Department of Public Health, 2003, http://tghealth-critiques.tripod.com/consen3.htm.
35. Kirk S, Rothblatt M. Medical, legal and workplace issues for the transsexual. Watertown, Massachusetts: Together Lifeworks, 1995.
36. Israel GE, Tarver DEI. Transgender care: recommended guidelines, practical information and personal accounts. Philadelphia: Temple University Press, 1997.
37. Bushong CW, Martin RA, Westwood KL. Introduction to the TransGenderCare medical feminising programme, http://www.transgendercare. com/medical/resources/tmf_program/tmf_program_intro.asp.
38. Steinbeck A. Hormonal medication for transsexuals. Venereology: interdisciplinary, Inter J Sex Health 1997;10:175-7.
39. Jin B, Turner L, Walters WAW, et al. The effects of chronic high dose androgen or oestrogen treatment on the human prostate. J Clin Endocrinol Metab 1996;81:4290-5.